BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

542678

CHCL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Cian Healthcare Limited Share Price Update

As of the latest trading session, Cian Healthcare Limited share price is currently at ₹ 3.12, which is down by ₹ -0.04 from its previous closing. Today, the stock has fluctuated between ₹ 3.12 and ₹ 3.22. Over the past year, Cian Healthcare Limited has achieved a return of -85.10 %. In the last month alone, the return has been -6.78 %. Read More...

Cian Healthcare Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    7.79

  • P/E Ratio (TTM)

    19.75

  • Beta

    0.39

  • Book Value / share

    24.72

  • Return on equity

    0.63%

  • EPS (TTM)

    0.16

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Cian Healthcare Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 58.75
Operating Expense 59.80
Net Profit 0.39
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.16
EBITDA 8.42
Effective Tax Rate (%) -3800.00
Particulars MAR 2023 (Values in Cr)
Revenue 67.56
Operating Expense 66.93
Net Profit 1.08
Net Profit Margin (%) 1.59
Earnings Per Share (EPS) 0.43
EBITDA 9.02
Effective Tax Rate (%) 10.00
Particulars MAR 2022 (Values in Cr)
Revenue 64.10
Operating Expense 66.88
Net Profit -2.28
Net Profit Margin (%) -3.55
Earnings Per Share (EPS) -0.91
EBITDA 5.33
Effective Tax Rate (%) 4.20
Particulars MAR 2021 (Values in Cr)
Revenue 72.38
Operating Expense 71.72
Net Profit 0.33
Net Profit Margin (%) 0.45
Earnings Per Share (EPS) 0.14
EBITDA 9.33
Effective Tax Rate (%) 50.74
Particulars MAR 2020 (Values in Cr)
Revenue 57.05
Operating Expense 57.69
Net Profit -0.07
Net Profit Margin (%) -0.12
Earnings Per Share (EPS) -0.03
EBITDA 8.33
Effective Tax Rate (%) 214.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.10
ROE % 0.39
ROCE % 4.66
Total Debt to Total Equity 1.01
EBITDA Margin 18.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 23.00
ROE % 3.41
ROCE % 6.59
Total Debt to Total Equity 1.10
EBITDA Margin 20.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.18
EBITDA Margin 6.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 24.92
ROE % 0.12
ROCE % 6.61
Total Debt to Total Equity 1.23
EBITDA Margin 16.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 24.90
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.25
EBITDA Margin 14.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.73
ROE % 0.63
ROCE % 4.43
Total Debt to Total Equity 0.68
EBITDA Margin 14.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 24.57
ROE % 1.77
ROCE % 5.54
Total Debt to Total Equity 0.70
EBITDA Margin 14.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.77
EBITDA Margin 8.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.62
ROE % 0.69
ROCE % 6.51
Total Debt to Total Equity 0.84
EBITDA Margin 13.43
Particulars MAR 2020 (Values in Cr)
Book Value / Share 25.48
ROE % -0.34
ROCE % 6.61
Total Debt to Total Equity 1.23
EBITDA Margin 14.90
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 161.17
Total Liabilities 161.17
Total Equity 57.74
Share Outstanding 24995764
Price to Book Ratio 0.84
Return on Assets (%) 0.15
Return on Capital (%) 0.22
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.32
Total Assets 160.47
Total Liabilities 160.47
Total Equity 57.48
Share Outstanding 24995764
Price to Book Ratio 1.14
Return on Assets (%) 1.26
Return on Capital (%) 1.72
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 165.93
Total Liabilities 165.93
Total Equity 55.45
Share Outstanding 24995764
Price to Book Ratio 0.79
Return on Assets (%) -3.33
Return on Capital (%) -4.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.32
Total Assets 157.25
Total Liabilities 157.25
Total Equity 58.24
Share Outstanding 23360764
Price to Book Ratio 0.44
Return on Assets (%) 0.03
Return on Capital (%) 0.04
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.45
Total Assets 156.53
Total Liabilities 156.53
Total Equity 58.19
Share Outstanding 23360764
Price to Book Ratio 0.59
Return on Assets (%) -2.41
Return on Capital (%) -3.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 142.89
Total Liabilities 142.89
Total Equity 61.81
Share Outstanding 24995764
Price to Book Ratio 0.84
Return on Assets (%) 0.27
Return on Capital (%) 0.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 140.63
Total Liabilities 140.63
Total Equity 61.42
Share Outstanding 24995764
Price to Book Ratio 1.14
Return on Assets (%) 0.76
Return on Capital (%) 1.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.22
Total Assets 139.78
Total Liabilities 139.78
Total Equity 60.34
Share Outstanding 24995764
Price to Book Ratio 0.79
Return on Assets (%) -1.62
Return on Capital (%) -2.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 134.63
Total Liabilities 134.63
Total Equity 59.87
Share Outstanding 23360764
Price to Book Ratio 0.44
Return on Assets (%) 0.24
Return on Capital (%) 0.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 134.68
Total Liabilities 134.68
Total Equity 59.54
Share Outstanding 23360764
Price to Book Ratio 0.59
Return on Assets (%) -0.05
Return on Capital (%) -0.07
Particulars MAR 2024 (Values in Cr)
Net Income 0.25
Cash from Operations 11.76
Cash from Investing -1.45
Cash from Financing -10.44
Net change in Cash -0.13
Free Cash Flow 11.92
Particulars MAR 2023 (Values in Cr)
Net Income 2.02
Cash from Operations 4.84
Cash from Investing 2.55
Cash from Financing -7.40
Net change in Cash -0.01
Free Cash Flow 5.27
Particulars MAR 2022 (Values in Cr)
Net Income -5.53
Cash from Operations 8.57
Cash from Investing 1.39
Cash from Financing -10.95
Net change in Cash -0.98
Free Cash Flow 25.89
Particulars MAR 2021 (Values in Cr)
Net Income 0.05
Cash from Operations 5.93
Cash from Investing 2.71
Cash from Financing -9.77
Net change in Cash -1.12
Free Cash Flow 6.49
Particulars MAR 2020 (Values in Cr)
Net Income -3.78
Cash from Operations -7.30
Cash from Investing -27.44
Cash from Financing 35.77
Net change in Cash 1.03
Free Cash Flow -6.34
Particulars MAR 2024 (Values in Cr)
Net Income 0.38
Cash from Operations 6.94
Cash from Investing -0.92
Cash from Financing -6.41
Net change in Cash -0.39
Free Cash Flow 7.08
Particulars MAR 2023 (Values in Cr)
Net Income 1.07
Cash from Operations 2.15
Cash from Investing -1.08
Cash from Financing -1.16
Net change in Cash -0.09
Free Cash Flow 2.39
Particulars MAR 2022 (Values in Cr)
Net Income -2.27
Cash from Operations 5.50
Cash from Investing -3.84
Cash from Financing -2.64
Net change in Cash -0.98
Free Cash Flow 22.16
Particulars MAR 2021 (Values in Cr)
Net Income 0.32
Cash from Operations 5.46
Cash from Investing -1.20
Cash from Financing -5.06
Net change in Cash -0.80
Free Cash Flow 5.87
Particulars MAR 2020 (Values in Cr)
Net Income -0.07
Cash from Operations -9.23
Cash from Investing -25.16
Cash from Financing 35.08
Net change in Cash 0.68
Free Cash Flow -1.89
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

Cian Healthcare Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
3.12 -1.26 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 3.10
  • 26 Days 3.30
  • 10 Days 3.10
  • 50 Days 3.50
  • 12 Days 3.10
  • 100 Days 4.30
  • 20 Days 3.20
  • 200 Days 7.40
3.14 PIVOT

First Support

3.13

First Resistance

3.18

Second Support

3.09

Second Resistance

3.19

Third Support

3.08

Third Resistance

3.23

RSI

39.49

ADX

73.55

MACD

-0.14

Williams % R

-29.17

Commodity Channel Index (CCI)

-31.91

Date

2025-04-29

Week

33333.00

Same Day

28000.00

Month

39889.00

1 Year

0.39

3 Year

0.49

Over 1 Month

-6.78%

down

Over 1 Year

-85.10%

down

Over 3 Months

4.29%

down

Over 3 Years

-45.48%

down

Over 6 Months

-26.16%

down

Over 5 Years

-31.85%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Cian Healthcare Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
72.89%
Promoter Holdings
27.1%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
34.48%
Name Shares Category
Pankaj Shriniwas Zanwar 3440000.0 (13.76%) Shareholding of Promoter and Promoter Group
Suraj Shriniwas Zanwar 2521847.0 (10.09%) Shareholding of Promoter and Promoter Group
Prakashchandra Rathi 2437153.0 (9.75%) Public Shareholding
Shakuntala Shriniwas Zanwar 510000.0 (2.04%) Shareholding of Promoter and Promoter Group
Dayal Tours And Travels India Private Limited 500000.0 (2.0%) Public Shareholding
Vikas Kumar Ekka 330000.0 (1.32%) Public Shareholding
Girija Amit Sharma 318000.0 (1.27%) Public Shareholding
Kavita Suraj Zanwar 302000.0 (1.21%) Shareholding of Promoter and Promoter Group
Vinay Kumar Tekriwal 288000.0 (1.15%) Public Shareholding
Sonali Dilip Sanklecha 286000.0 (1.14%) Public Shareholding
Girish Dargad 1050.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Cian Healthcare Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Cian Healthcare Limited Share Price

Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of 'Cian Healthcare Private Limited' on January 07, 2003. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Cian Healthcare Limited' pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018.

The Company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The Company has a full-fledged F & D and regulatory department. The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration.

The Company started manufacturing unit at Roorkee in Uttarakhand in 2013. It develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, alongwith 10 sales division focused on developing and growing its engagements in specialist and super specialist division. It works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.

In May 2019, the Company came up with a Public Issue of 62,16,000 Equity Shares. The Company has product approvals under the license issued by Drug Controlling & Licensing Authority Uttarkhand, for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology. It manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's.

Cian developed more than 1,000 formulations and 2000 brands for domestic market under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals.

Parent organization Indian Private
NSE symbol [-]
Founded 2003
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Cian Healthcare Ltd?

Answer Field

The share price of Cian Healthcare Ltd for NSE is ₹ 0.00 and for BSE is ₹ 3.12.

What is the Market Cap of Cian Healthcare Ltd?

Answer Field

The market cap of Cian Healthcare Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 7.80 Cr. as of now.

What is the 52 Week High and Low of Cian Healthcare Ltd?

Answer Field

The 52 Week High and Low of Cian Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.50 and ₹ 2.97.

How to Buy Cian Healthcare Ltd share?

Answer Field

You can trade in Cian Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Cian Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -85.10%.

What is the Current Share Price of Cian Healthcare Ltd?

Answer Field

Cian Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 3.12 as on Apr 30 2025 01:37 PM.

What is the Market Cap of Cian Healthcare Ltd Share?

Answer Field

The market cap of Cian Healthcare Ltd for NSE ₹ 0.0 & for BSE ₹ 7.80 as on Apr 30 2025 01:37 PM.

What is the P/E Ratio of Cian Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 01:37 PM the price-to-earnings (PE) ratio for Cian Healthcare Ltd share is 19.75.

What is the PB ratio of Cian Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 01:37 PM, the price-to-book (PB) ratio for Cian Healthcare Ltd share is 24.72.

How to Buy Cian Healthcare Ltd Share?

Answer Field

You can trade in Cian Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Cian Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Cian Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Cian Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|